Besides, by analyzing the relationship between CEP55 and some clinicopathological features of colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) patients, we found that in COAD, the expression of CEP55 in tumor patients over 40 years old increased with age. Here, CEP55 is linked to colon adenocarcinoma.